Concord Wealth Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.7K | Hold |
267
| – | – | ﹤0.01% | 414 |
|
|
2025
Q1 | $26.9K | Sell |
267
-297
| -53% | -$30K | ﹤0.01% | 399 |
|
|
2024
Q4 | $50.4K | Hold |
564
| – | – | 0.01% | 327 |
|
|
2024
Q3 | $47.3K | Hold |
564
| – | – | 0.01% | 345 |
|
|
2024
Q2 | $43.4K | Sell |
564
-57
| -9% | -$4.39K | 0.01% | 329 |
|
|
2024
Q1 | $42.5K | Hold |
621
| – | – | 0.01% | 378 |
|
|
2023
Q4 | $35.9K | Sell |
621
-280
| -31% | -$16.2K | 0.01% | 401 |
|
|
2023
Q3 | $47.6K | Buy |
901
+61
| +7% | +$3.22K | 0.01% | 386 |
|
|
2023
Q2 | $45.4K | Hold |
840
| – | – | 0.01% | 380 |
|
|
2023
Q1 | $42K | Buy |
840
+314
| +60% | +$15.7K | 0.01% | 372 |
|
|
2022
Q4 | $24.3K | Buy |
+526
| New | +$24.3K | 0.01% | 495 |
|
|
2022
Q3 | – | Sell |
-574
| Closed | -$21K | – | 285 |
|
|
2022
Q2 | $21K | Sell |
574
-1,563
| -73% | -$57.2K | 0.01% | 532 |
|
|
2022
Q1 | $95K | Sell |
2,137
-74
| -3% | -$3.29K | 0.02% | 308 |
|
|
2021
Q4 | $94K | Buy |
2,211
+1,578
| +249% | +$67.1K | 0.02% | 318 |
|
|
2021
Q3 | $27K | Sell |
633
-1,023
| -62% | -$43.6K | 0.01% | 324 |
|
|
2021
Q2 | $71K | Buy |
1,656
+259
| +19% | +$11.1K | 0.02% | 291 |
|
|
2021
Q1 | $54K | Buy |
1,397
+1,368
| +4,717% | +$52.9K | 0.02% | 324 |
|
|
2020
Q4 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 601 |
|